Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/15/2012WO2012032764A1 Ttll4 peptides and vaccines containing the same
03/15/2012WO2012032520A1 Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
03/15/2012WO2012032360A2 Novel use
03/15/2012WO2012032143A1 Phosphorylated twist1 and metastasis
03/15/2012WO2012032112A1 Stem cell culture media and methods
03/15/2012WO2012032068A2 Compounds and methods
03/15/2012WO2012031778A1 Use of erythropoietin for scar-free healing of wounds or tissue defects
03/15/2012WO2012031518A1 Localized pegylated modifications of exendin-4 analogs and use thereof
03/15/2012WO2012031342A2 Polymer system and method for encapsulating human amylin and agonist analogues, and use thereof; released amylin functional evaluation method
03/15/2012WO2012031328A1 Treatments for substance abuse and addiction
03/15/2012WO2012031327A1 Modified relaxin polypeptides
03/15/2012WO2012031326A1 Single chain relaxin polypeptides
03/15/2012WO2012006516A3 Protein kinase c activators and anticoagulant for the treatment of stroke
03/15/2012WO2011160845A3 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment
03/15/2012WO2011160062A3 Compositions and methods for treating inflammatory conditions
03/15/2012WO2011159951A3 Targeting tumor associated macrophages using bisphosphonate-loaded particles
03/15/2012WO2011159810A3 Compositions and methods for the treatment of atherosclerosis
03/15/2012WO2011150897A3 Cancer therapy method
03/15/2012WO2011146885A3 Compositions and methods for lentiviral expression of apoa-1 or variants thereof using spliceosome mediated rna trans-splicing
03/15/2012WO2011143152A3 Acth for treatment of amyotrophic lateral sclerosis
03/15/2012WO2011140337A3 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
03/15/2012WO2011121289A3 Peptides and their use
03/15/2012WO2011118981A9 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer
03/15/2012WO2011100234A3 Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods
03/15/2012WO2011078394A3 Sustained-release formulation
03/15/2012WO2011076368A3 Topical ophthalmic peptide formulation
03/15/2012WO2011069629A3 Pharmaceutical composition comprising oligopeptides, preferably cilengitide
03/15/2012WO2011069037A3 Stabilization and storage of biological pharmaceutical compositions
03/15/2012WO2011045352A3 Spleen tyrosine kinase and brain cancers
03/15/2012WO2011025996A3 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
03/15/2012WO2011020319A8 Fusion protein regulating plasma glucose and lipid, its preparation method and use
03/15/2012WO2010120365A3 Protein-carrier conjugates
03/15/2012US20120066781 Phytases, nucleic acids encoding them and methods for making and using them
03/15/2012US20120066779 Hepatitis c receptor protein cd81
03/15/2012US20120066775 Stresscopins and their Uses
03/15/2012US20120065574 Isoform nell-1 peptide
03/15/2012US20120065429 Water-soluble polymer alkanals
03/15/2012US20120065385 Dendritic cell co-stimulatory molecules
03/15/2012US20120065374 Dendritic cell co-stimulatory molecules
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065253 Genetic modification of targeted regions of the cardiac conduction system
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
03/15/2012US20120065148 Phosphodiesterase 4d7 as prostate cancer marker
03/15/2012US20120065147 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
03/15/2012US20120065146 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
03/15/2012US20120065145 Alkylating agent combinations in the treatment of cancer
03/15/2012US20120065144 Peptide for the Prophylactic or Therapeutic Treatment of Skin Tumors in Initial Stages
03/15/2012US20120065143 Dose and localization of botulinum toxins in skin and muscle
03/15/2012US20120065142 Novel solid materials of and methods for obtaining them
03/15/2012US20120065141 Stabilized biodegradable neurotoxin implants
03/15/2012US20120065140 Biomarkers for the Diagnosis of Autoimmune Disease
03/15/2012US20120065139 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
03/15/2012US20120065138 Lipids, lipid complexes and use thereof
03/15/2012US20120065137 Therapeutics for trauma induced factor v consumptive coagulopathy
03/15/2012US20120065136 Recombinant factor viii having enhanced stability following mutation at the a1-c2 domain interface
03/15/2012US20120065135 Genetically Modified TFPI And Method Of Making The Same
03/15/2012US20120065134 Cd40-l inhibitory phylomer peptides
03/15/2012US20120065133 Artificial Oxygen Transport Protein
03/15/2012US20120065132 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
03/15/2012US20120065131 Compositions and methods for topical application and transdermal delivery of an oligopeptide
03/15/2012US20120065130 Methods for treating congestive heart failure
03/15/2012US20120065128 Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
03/15/2012US20120065126 Pharmaceutical Compositions Containing Antifungal Peptides
03/15/2012US20120065125 Methods and compositions for the treatment of cancer or other diseases
03/15/2012US20120065124 Cell-penetrating peptides
03/15/2012US20120065123 Synthetic Antibodies
03/15/2012US20120065122 Pharmaceutical Composition and Method for Modulating Slow Myosin
03/15/2012US20120064626 B7-h7 antibodies and method of use
03/15/2012US20120064621 Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide
03/15/2012US20120064572 Bacterial Virulence Factors And Uses Thereof
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064524 Tumor suppressor gene, p47ing3
03/15/2012US20120064182 Cosmetic or dermatological preparation comprising collagen, chitosan, glycosylaminoglycan and cell growth promoting peptide and/or cellular complex
03/15/2012US20120064176 Composition for preventing and treating fatty liver
03/15/2012US20120064165 Treatment of tissue adhesion
03/15/2012US20120064160 Fibrate-statin Combinations with Reduced Fed-fasted Effects
03/15/2012US20120064150 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
03/15/2012US20120064127 Composition for improving membrane composition and functioning of cells
03/15/2012US20120064125 Agr-mediated inhibition of methicillin resistant staphylococcus aureus
03/15/2012US20120064101 Compounds and Methods Useful for Detection and Treatment of Cancer
03/15/2012US20120064091 Dysfunction of the mitochondrial respiratory chain, methods for diagnosis, treatment and follow-up
03/15/2012US20120064090 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug
03/15/2012US20120064087 Methods to diagnose a required regulation of trophoblast invasion
03/15/2012US20120064086 High concentration antibody and protein formulations
03/15/2012US20120064084 Signal transduction protein tab2
03/15/2012US20120064079 Compositions and Methods for Preventing Erythropoietin-Associated Hypertension
03/15/2012US20120064075 Chimeric factor vii molecules with enhanced half life and methods of use
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120064061 Adhesive composition comprising tannin, poly(ethylene glycol), and water, lower alcohol or mixture thereof
03/15/2012US20120064059 Fusion proteins
03/15/2012US20120064058 Compositions for protein-based dietary products
03/15/2012US20120064057 Novel adamts-13 mutant
03/15/2012US20120064056 Dichloracetate in combination with clinically high levels of cardioprotective or hemodynamic drugs
03/15/2012US20120064055 Methods for Treating Lysosomal Acid Lipase Deficiency in Patients
03/15/2012US20120064048 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/15/2012US20120064039 Use of Guanylyl Cyclase C Agonists to Suppress Appetite
03/15/2012US20120064037 Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
03/15/2012US20120064036 Methods of Administration of Thrombopoietin Agonist Compounds
03/15/2012US20120064035 Vaccine immunotherapy
03/15/2012US20120064034 Peptidomimetic protease inhibitors
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 3163